Detall de la convocatòria

Característiques

Característica
Objectiu de la convocatòria
This grant supports innovative, high-impact projects with the potential to transform neuroendocrine cancer research and treatment. Projects should foster multidisciplinary collaboration and include substantial aims to be completed within a four-year timeframe, comparable in scope to an NIH R01 grant.
Característiques principals
  • Research Areas of Interest
    - Early Detection: Approaches to identify neuroendocrine cancer at earlier, more treatable stages, including biomarker and assay development, imaging, and risk prediction models.
    - New Therapeutic Development: Discovery and advancement of innovative treatments, such as targeted therapies, immunotherapies, and novel modalities.
    - Precision Medicine: Strategies to match therapies to individual patients based on tumor biology, biomarkers, and disease characteristics.

  • Tumor Types:
    Neuroendocrine neoplasms (NENs) across sites and stages, including well-differentiated neuroendocrine tumors (G1–G3) and poorly differentiated extrapulmonary neuroendocrine carcinoma (epNEC), including metastatic, unknown primary, and hereditary cases (e.g., MEN1, VHL, NF1, SDHx) when NEN biology is central. MiNEN are eligible when the neuroendocrine component is biologically or clinically driving; neuroendocrine features within other primary cancer types are not eligible.

    A complete list of eligible NEN types and out-of-scope tumor types is provided in the guidelines.
    • Lloc de presentació
    HMRIB and PSMAR staff who need more information should contact:
    Research Grants and Contracts Office. C/ Doctor Aiguader, 88. 08003 Barcelona. Tel.: 93.316.04.00.
    Carol Barnwell: [email protected] Ext.: 1670
    Marta López: [email protected] Ext.: 1576
    Júlia Vidal: [email protected] Ext.: 1736
    Convocatòria (URL)
    https://netrf.org/for-researchers/about/funding-for-researchers/accelerator/
    Informació addicional
    This call follows a two-step procedure. Letters of intent must be submitted through the Proposal Central platform by 5:00 PM ET on the deadline date.
    Requisits
  • Applicants must have an MD, PhD, MD/PhD, or equivalent degree and hold a faculty appointment at the Assistant Professor level or above (or equivalent position). Research track faculty are eligible to apply.
  • Applicants must have the skills, knowledge, and resources necessary to carry out the proposed research.
  • Eligible organizations include public or private institutions, such as universities, colleges, hospitals, and laboratories, both within and outside of the United States. Applications from the biotech, pharmaceutical, or for-profit life sciences industries are not eligible.
  • Projects that bring together investigators from diverse scientific disciplines are highly encouraged.
    • Dotació
    $200,000 per year
    Durada
    4 years

    Arxius

    Arxiu
    AA-RFA-Final-2026.pdf